Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Bendas

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Archiv Der Pharmazie|February 7, 2022
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer modelsLukas M Gockel, Vladlena Pfeifer, Fabian Baltes, et al.
Seminars in Thrombosis and Hemostasis|February 16, 2015
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progressionUrsula Gerber, Sebastian G Hoß, Anna Shteingauz, et al.
In Vivo (Athens, Greece)|July 2, 2013
Targeting cancer with a bi-functional peptide: in vitro and in vivo resultsKaroline Meschenmoser, Young Kim, Sebastian Franken, et al.
Thrombosis and Haemostasis|September 21, 2018
Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?Sebastian G Hoß, Manuel Grundmann, Tobias Benkel, et al.
ACS Applied Materials & Interfaces|February 3, 2021
Inhibition of Tumor-Host Cell Interactions Using Synthetic Heparin MimeticsLukas M Gockel, Martin Heyes, Honglian Li, et al.
The Journal of Biological Chemistry|April 20, 2012
Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursorsAnna Müller, Daniela Münch, Yvonne Schmidt, et al.
Chemical Communications (Cambridge, England)|September 13, 2022
Development of the first non-hydroxamate selective HDAC6 degradersTim Keuler, Beate König, Nico Bückreiß, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2014
Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancinDaniela Münch, Ina Engels, Anna Müller, et al.
Translational Oncology|June 11, 2014
Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinomaUte Schütte, Savita Bisht, Lukas C Heukamp, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Target Engagement Studies and Kinetic Live-Cell Degradation Assays Enable the Systematic Characterization of Histone Deacetylase 6 DegradersMaria Hanl, Felix Feller, Irina Honin, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Archiv Der Pharmazie|February 7, 2022
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer modelsLukas M Gockel, Vladlena Pfeifer, Fabian Baltes, et al.
Seminars in Thrombosis and Hemostasis|February 16, 2015
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progressionUrsula Gerber, Sebastian G Hoß, Anna Shteingauz, et al.
In Vivo (Athens, Greece)|July 2, 2013
Targeting cancer with a bi-functional peptide: in vitro and in vivo resultsKaroline Meschenmoser, Young Kim, Sebastian Franken, et al.
Thrombosis and Haemostasis|September 21, 2018
Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?Sebastian G Hoß, Manuel Grundmann, Tobias Benkel, et al.
ACS Applied Materials & Interfaces|February 3, 2021
Inhibition of Tumor-Host Cell Interactions Using Synthetic Heparin MimeticsLukas M Gockel, Martin Heyes, Honglian Li, et al.
The Journal of Biological Chemistry|April 20, 2012
Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursorsAnna Müller, Daniela Münch, Yvonne Schmidt, et al.
Chemical Communications (Cambridge, England)|September 13, 2022
Development of the first non-hydroxamate selective HDAC6 degradersTim Keuler, Beate König, Nico Bückreiß, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2014
Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancinDaniela Münch, Ina Engels, Anna Müller, et al.
Translational Oncology|June 11, 2014
Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinomaUte Schütte, Savita Bisht, Lukas C Heukamp, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Target Engagement Studies and Kinetic Live-Cell Degradation Assays Enable the Systematic Characterization of Histone Deacetylase 6 DegradersMaria Hanl, Felix Feller, Irina Honin, et al.
Pageof 11